150 related articles for article (PubMed ID: 30012177)
1. Motor neuron and pancreas homeobox 1/HLXB9 promotes sustained proliferation in bladder cancer by upregulating CCNE1/2.
Chen M; Wu R; Li G; Liu C; Tan L; Xiao K; Ye Y; Qin Z
J Exp Clin Cancer Res; 2018 Jul; 37(1):154. PubMed ID: 30012177
[TBL] [Abstract][Full Text] [Related]
2. Motor Neuron and Pancreas Homeobox 1 (MNX1) Is Involved in Promoting Squamous Cervical Cancer Proliferation via Regulating Cyclin E.
Xiao L; Hong L; Zheng W
Med Sci Monit; 2019 Aug; 25():6304-6312. PubMed ID: 31436258
[TBL] [Abstract][Full Text] [Related]
3. Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells.
Wu Y; Zheng Q; Li Y; Wang G; Gao S; Zhang X; Yan X; Zhang X; Xie J; Wang Y; Sun X; Meng X; Yin B; Wang B
J Exp Clin Cancer Res; 2019 Aug; 38(1):376. PubMed ID: 31455378
[TBL] [Abstract][Full Text] [Related]
4. MNX1 reduces sensitivity to anoikis by activating TrkB in human glioma cells.
Jiang L; Chen S; Zhao D; Yan J; Chen J; Yang C; Zheng G
Mol Med Rep; 2018 Sep; 18(3):3271-3279. PubMed ID: 30066929
[TBL] [Abstract][Full Text] [Related]
5. The tumor-suppressor gene Nkx2.8 suppresses bladder cancer proliferation through upregulation of FOXO3a and inhibition of the MEK/ERK signaling pathway.
Yu C; Zhang Z; Liao W; Zhao X; Liu L; Wu Y; Liu Z; Li Y; Zhong Y; Chen K; Li J; Zhou F; Song L
Carcinogenesis; 2012 Mar; 33(3):678-86. PubMed ID: 22223847
[TBL] [Abstract][Full Text] [Related]
6. MNX1 Promotes Malignant Progression of Cervical Cancer via Repressing the Transcription of p21
Zhu B; Wu Y; Luo J; Zhang Q; Huang J; Li Q; Xu L; Lu E; Ren B
Front Oncol; 2020; 10():1307. PubMed ID: 32850410
[TBL] [Abstract][Full Text] [Related]
7. Long Noncoding RNA MNX1-AS1 Knockdown Inhibits Cell Proliferation and Migration in Ovarian Cancer.
Lv Y; Li H; Li F; Liu P; Zhao X
Cancer Biother Radiopharm; 2017 Apr; 32(3):91-99. PubMed ID: 28414551
[TBL] [Abstract][Full Text] [Related]
8. LncRNA MNX1-AS1: A novel oncogenic propellant in cancers.
Li T; Zhou S; Yang Y; Xu Y; Gong X; Cheng Y; Wang Y
Biomed Pharmacother; 2022 May; 149():112801. PubMed ID: 35290890
[TBL] [Abstract][Full Text] [Related]
9. HLXB9 gene expression, and nuclear location during in vitro neuronal differentiation in the SK-N-BE neuroblastoma cell line.
Leotta CG; Federico C; Brundo MV; Tosi S; Saccone S
PLoS One; 2014; 9(8):e105481. PubMed ID: 25136833
[TBL] [Abstract][Full Text] [Related]
10. MNX1 facilitates the malignant progress of lung adenocarcinoma through transcriptionally upregulating CCDC34.
Wu J; Yue C; Xu W; Li H; Zhu J; Li L
Oncol Lett; 2023 Aug; 26(2):325. PubMed ID: 37415626
[TBL] [Abstract][Full Text] [Related]
11. The homeobox gene HLXB9 is upregulated in a morphological subset of poorly differentiated hepatocellular carcinoma.
Wilkens L; Jaggi R; Hammer C; Inderbitzin D; Giger O; von Neuhoff N
Virchows Arch; 2011 Jun; 458(6):697-708. PubMed ID: 21484430
[TBL] [Abstract][Full Text] [Related]
12. Inactivating the permanent neonatal diabetes gene Mnx1 switches insulin-producing β-cells to a δ-like fate and reveals a facultative proliferative capacity in aged β-cells.
Pan FC; Brissova M; Powers AC; Pfaff S; Wright CV
Development; 2015 Nov; 142(21):3637-48. PubMed ID: 26534984
[TBL] [Abstract][Full Text] [Related]
13. MNX1 Promotes Anti-HER2 Therapy Sensitivity via Transcriptional Regulation of CD-M6PR in HER2-Positive Breast Cancer.
Chi W; Xiu B; Xiong M; Wang X; Li P; Zhang Q; Hou J; Sang Y; Zhou X; Chen M; Zheng S; Zhang L; Xue J; Chi Y; Wu J
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203393
[TBL] [Abstract][Full Text] [Related]
14. Mir-135a enhances cellular proliferation through post-transcriptionally regulating PHLPP2 and FOXO1 in human bladder cancer.
Mao XP; Zhang LS; Huang B; Zhou SY; Liao J; Chen LW; Qiu SP; Chen JX
J Transl Med; 2015 Mar; 13():86. PubMed ID: 25888950
[TBL] [Abstract][Full Text] [Related]
15. C14orf166 is a high-risk biomarker for bladder cancer and promotes bladder cancer cell proliferation.
Chen M; Ye Y; Zou B; Guo S; Zhou F; Lu K; Liu J; Xu Z; Han H; Liu Z; Li Y; Yao K; Liu C; Qin Z
J Transl Med; 2016 Feb; 14():55. PubMed ID: 26905879
[TBL] [Abstract][Full Text] [Related]
16. MNX1-AS1 is a novel biomarker for predicting clinical progression and poor prognosis in lung adenocarcinoma.
Yang R; Wang L; Han M
J Cell Biochem; 2019 May; 120(5):7222-7228. PubMed ID: 30506837
[TBL] [Abstract][Full Text] [Related]
17. Pancreas dorsal lobe agenesis and abnormal islets of Langerhans in Hlxb9-deficient mice.
Harrison KA; Thaler J; Pfaff SL; Gu H; Kehrl JH
Nat Genet; 1999 Sep; 23(1):71-5. PubMed ID: 10471502
[TBL] [Abstract][Full Text] [Related]
18. LncROR Promotes Bladder Cancer Cell Proliferation, Migration, and Epithelial-Mesenchymal Transition.
Chen Y; Peng Y; Xu Z; Ge B; Xiang X; Zhang T; Gao L; Shi H; Wang C; Huang J
Cell Physiol Biochem; 2017; 41(6):2399-2410. PubMed ID: 28463831
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of E2F8 promotes cell proliferation and tumorigenicity in breast cancer by modulating G1/S phase transition.
Ye L; Guo L; He Z; Wang X; Lin C; Zhang X; Wu S; Bao Y; Yang Q; Song L; Lin H
Oncotarget; 2016 Apr; 7(17):23757-71. PubMed ID: 26992224
[TBL] [Abstract][Full Text] [Related]
20. MNX1 (HLXB9) mutations in Currarino patients.
Garcia-Barceló MM; Lui VC; So MT; Miao X; Leon TY; Yuan ZW; Ngan ES; Ehsan T; Chung PH; Khong PL; Wong KK; Tam PK
J Pediatr Surg; 2009 Oct; 44(10):1892-8. PubMed ID: 19853743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
